|
| 36710205 | Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. | Eur Urol | 2024 |
| 36179990 | External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. | Int J Radiat Oncol Biol Phys | 2023 |
| 37862103 | Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium. | J Med Internet Res | 2023 |
| 37393186 | A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy. | Brachytherapy | 2023 |
| 37059334 | Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study. | Radiother Oncol | 2023 |
| 36592721 | Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2023 |
| 36717286 | A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study. | Eur Urol | 2023 |
| 36566906 | Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2023 |
| 34303033 | Early Prostate-Specific Antigen Kinetics for Low- and Intermediate-Risk Prostate Cancer Treated With Definitive Radiation Therapy. | Pract Radiat Oncol | 2022 |
| 35536148 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up. | J Urol | 2022 |
| 35536144 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. | J Urol | 2022 |
| 35536141 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions. | J Urol | 2022 |
| 35776901 | Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415. | JCO Clin Cancer Inform | 2022 |
| 36910578 | Clinical Validation of an Alternative Specimen Collection Kit for SARS-CoV-2 Testing at Fox Chase Cancer Center. | J Biomol Tech | 2022 |
| 35130494 | Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine. | J Natl Compr Canc Netw | 2022 |
| 35050303 | Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. | JAMA Oncol | 2022 |
| 34740768 | Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526). | Int J Radiat Oncol Biol Phys | 2022 |
| 33390282 | The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy. | Eur Urol | 2021 |
| 33852571 | Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415. | PLoS One | 2021 |
| 33545689 | NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. | J Natl Compr Canc Netw | 2021 |
| 33539968 | A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients. | Int J Radiat Oncol Biol Phys | 2021 |
| 33577175 | Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes. | Am J Clin Oncol | 2021 |
| 34972513 | A personalized decision aid for prostate cancer shared decision making. | BMC Med Inform Decis Mak | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |
| 33985797 | Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. | Eur Urol | 2021 |
| 34196715 | Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. | JAMA Netw Open | 2021 |
| 30992160 | Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. | Eur Urol | 2020 |
| 33090219 | Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. | JAMA Oncol | 2020 |
| 32663537 | Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. | Radiother Oncol | 2020 |
| 32769406 | Pelvic Reirradiation Utilizing Pulsed Low-dose Rate Radiation Therapy. | Am J Clin Oncol | 2020 |
| 32698974 | Less Is More: Treatment of Locally Advanced Small Cell Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2020 |
| 32219410 | A War on Two Fronts: Cancer Care in the Time of COVID-19. | Ann Intern Med | 2020 |
| 32391232 | Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis. | Cureus | 2020 |
| 32119599 | Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer. | J Clin Oncol | 2020 |
| 31326500 | Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer. | Eur Urol Oncol | 2020 |
| 30312717 | A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526). | Int J Radiat Oncol Biol Phys | 2019 |
| 31540746 | Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. | Radiother Oncol | 2019 |
| 30860948 | Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. | J Clin Oncol | 2019 |
| 31085757 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2019 |
| 30959123 | Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. | Int J Radiat Oncol Biol Phys | 2019 |
| 30526194 | Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. | J Clin Oncol | 2019 |
| 27014930 | Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. | Am J Clin Oncol | 2018 |
| 29913254 | Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2018 |
| 30202809 | Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. | Adv Radiat Oncol | 2018 |
| 29976500 | Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. | Int J Radiat Oncol Biol Phys | 2018 |
| 30316827 | Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. | Lancet Oncol | 2018 |
| 29509865 | Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. | JAMA | 2018 |
| 29304991 | A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. | Pract Radiat Oncol | 2018 |
| 29030906 | Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer. | J Med Imaging Radiat Oncol | 2018 |
| 27452951 | Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. | Eur Urol | 2017 |